FDA.reportPublic FDA data

sulfabenzamide 184 MG / sulfacetamide sodium 144 MG / sulfathiazole 172 MG Vaginal Insert

RxCUI
1012228
RxNorm name
sulfabenzamide 184 MG / sulfacetamide sodium 144 MG / sulfathiazole 172 MG Vaginal Insert
Term type
SCD
Status
Active
Updated
2026-06-13 07:07:31

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
102010
Active start
102010
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
sulfacetamide sodium144 MG / 1 EACHsulfacetamidesulfacetamide sodium
sulfathiazole172 MG / 1 EACHsulfathiazolesulfathiazole
sulfabenzamide184 MG / 1 EACHsulfabenzamidesulfabenzamide

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Vaginal Insert2107950

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
sulfacetamide10169
sulfathiazole10193
sulfabenzamide37320

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
RXNAV_STRsulfabenzamide 184 MG / sulfacetamide sodium 144 MG / sulfathiazole 172 MG Vaginal InsertNAMES
RxNorm Namesulfabenzamide 184 MG / sulfacetamide sodium 144 MG / sulfathiazole 172 MG Vaginal InsertNAMES
RxNorm Synonymsulfabenzamide 0.037 MG/MG / sulfacetamide sodium 0.0286 MG/MG / sulfathiazole 0.0342 MG/MG Vaginal InsertNAMES
RxNorm Synonymsulfabenzamide 3.7 % / sulfacetamide sodium 2.86 % / sulfathiazole 3.42 % Vaginal InsertNAMES
TTYSCDATTRIBUTES
RxCUI1012228CODES
MMSL_CODEBD3753CODES
MMSL_CODECD3753CODES

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11SourceActive
00062544175rxnav_historical
52493038720rxnav_historical

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCD10AFAntiinfectives for treatment of acneATC1-4sulfacetamide
ATCJ01EBShort-acting sulfonamidesATC1-4sulfathiazole
ATCS01ABSulfonamidesATC1-4sulfacetamide
ATCD06BASulfonamidesATC1-4sulfathiazole
FDASPLD013449SulfonamidesCHEMhas_chemical_structuresulfacetamide
FDASPLN0000175503Sulfonamide AntibacterialEPChas_epcsulfacetamide
MEDRTD013409SulfacetamideCHEMhas_ingredientsulfacetamide sodium
MEDRTD013409SulfacetamideCHEMhas_ingredientsulfacetamide
MEDRTD000077589SulfathiazoleCHEMhas_ingredientsulfathiazole
MEDRTD013449SulfonamidesCHEMhas_ingredientsulfabenzamide
MEDRTD003320Corneal UlcerDISEASEmay_treatsulfacetamide sodium
MEDRTD003320Corneal UlcerDISEASEmay_treatsulfacetamide
MEDRTD012628Dermatitis, SeborrheicDISEASEmay_treatsulfacetamide
MEDRTD012628Dermatitis, SeborrheicDISEASEmay_treatsulfacetamide sodium
MEDRTD004342Drug HypersensitivityDISEASEci_withsulfabenzamide
MEDRTD004342Drug HypersensitivityDISEASEci_withsulfacetamide
MEDRTD004342Drug HypersensitivityDISEASEci_withsulfacetamide sodium
MEDRTD004427Ear DiseasesDISEASEmay_treatsulfacetamide
MEDRTD004427Ear DiseasesDISEASEmay_treatsulfacetamide sodium
MEDRTD016905Gram-Negative Bacterial InfectionsDISEASEmay_treatsulfathiazole
MEDRTD016908Gram-Positive Bacterial InfectionsDISEASEmay_treatsulfathiazole
MEDRTD007231Infant, NewbornDISEASEci_withsulfacetamide
MEDRTD007231Infant, NewbornDISEASEci_withsulfacetamide sodium
MEDRTD011247PregnancyDISEASEci_withsulfabenzamide
MEDRTD051437Renal InsufficiencyDISEASEci_withsulfabenzamide
MEDRTD017192Skin Diseases, BacterialDISEASEmay_treatsulfacetamide sodium
MEDRTD017192Skin Diseases, BacterialDISEASEmay_treatsulfacetamide
MEDRTD014141TrachomaDISEASEmay_treatsulfacetamide sodium
MEDRTD014141TrachomaDISEASEmay_treatsulfacetamide
MEDRTD014627VaginitisDISEASEmay_treatsulfathiazole
MEDRTD014627VaginitisDISEASEmay_treatsulfabenzamide
MEDRTN0000009946Para-Aminobenzoic Acid InhibitorsMOAhas_moasulfacetamide sodium
MEDRTN0000009946Para-Aminobenzoic Acid InhibitorsMOAhas_moasulfabenzamide
MEDRTN0000009946Para-Aminobenzoic Acid InhibitorsMOAhas_moasulfathiazole
MEDRTN0000009946Para-Aminobenzoic Acid InhibitorsMOAhas_moasulfacetamide
MEDRTN0000008344Cellular Growth Phase ArrestPEhas_pesulfacetamide
MEDRTN0000008344Cellular Growth Phase ArrestPEhas_pesulfacetamide sodium
MEDRTN0000008347Cellular Synthetic Activity AlterationPEhas_pesulfabenzamide
MEDRTN0000008347Cellular Synthetic Activity AlterationPEhas_pesulfacetamide
MEDRTN0000008347Cellular Synthetic Activity AlterationPEhas_pesulfathiazole
MEDRTN0000008347Cellular Synthetic Activity AlterationPEhas_pesulfacetamide sodium
MEDRTN0000009935Decreased Folic Acid ModificationPEhas_pesulfacetamide
MEDRTN0000009935Decreased Folic Acid ModificationPEhas_pesulfacetamide sodium

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESTTYSCD
CODESMMSL_CODEBD3753
CODESMMSL_CODECD3753
CODESRxCUI1012228
CODESSNOMEDCT371429006
CODESVUID4005295
NAMESPrescribable Synonymsulfabenzamide 184 MG / sulfacetamide sodium 143.75 MG / sulfathiazole 172.5 MG Vaginal Insert
NAMESRXNAV_STRsulfabenzamide 184 MG / sulfacetamide sodium 144 MG / sulfathiazole 172 MG Vaginal Insert
NAMESRxNorm Namesulfabenzamide 184 MG / sulfacetamide sodium 144 MG / sulfathiazole 172 MG Vaginal Insert
NAMESRxNorm Synonymsulfabenzamide 0.037 MG/MG / sulfacetamide sodium 0.0286 MG/MG / sulfathiazole 0.0342 MG/MG Vaginal Insert
NAMESRxNorm Synonymsulfabenzamide 3.7 % / sulfacetamide sodium 2.86 % / sulfathiazole 3.42 % Vaginal Insert
SOURCESSourceUS Edition of SNOMED_CT